Thermo Fisher Scientific (TMO) said late Thursday its board authorized the repurchase of up to $5 billion of common shares, replacing an existing buyback authorization.
The company also maintained its quarterly dividend at $0.47 per share, payable Jan. 15, 2027, to stockholders of record Dec. 15.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.